Our guest on this ALCSI podcast is Dr. Drew Moghanaki. Dr. Moghanaki is the Chief of Thoracic Oncology at UCLA Health’s Department of Radiation Oncology and co-directs the VA Greater Los Angeles Lung Precision Oncology Program. He is well recognized for his expertise in radiation therapy treatments for patients with non-small cell lung cancer, small-cell lung cancer, and thymoma. Dr. Moghanaki has also been working on lung cancer research, and leads multiple national research efforts, including the VALOR phase III clinical trial, which investigates stereotactic body radiation therapy or stereotactic ablative radiotherapy as a safer and more effective alternative to surgery. Your podcast hosts are Priyanka Senthil, Jacob Rashap, Pranav Mandyam, and Sam Schwartz. Lung cancer is the leading cause of cancer death in the world. Large clinical trials have shown that lung cancer screening through low-dose computed tomography (CT) reduces lung cancer mortality by up to 33%. In fact, if every high-risk American were to get screened right now, thousands of lives could be saved this year alone. However, less than 5% of high-risk Americans are currently getting screened. Visit our website at https://www.alcsi.org/ for free educational resources and webinars on lung cancer and lung cancer screening. Email: info@alcsi.org Twitter: @AmLungCSI Instagram: @amlungcsi